| 000 | 01859 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513125925.0 | ||
| 264 | 0 | _c19971031 | |
| 008 | 199710s 0 0 eng d | ||
| 022 | _a1077-4114 | ||
| 024 | 7 |
_a10.1097/00043426-199709000-00006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPappo, A S | |
| 245 | 0 | 0 |
_aA phase II trial of high-dose methotrexate in previously untreated children and adolescents with high-risk unresectable or metastatic rhabdomyosarcoma. _h[electronic resource] |
| 260 |
_bJournal of pediatric hematology/oncology _c |
||
| 300 |
_a438-42 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadverse effects |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aRadiography |
| 650 | 0 | 4 |
_aRhabdomyosarcoma _xdiagnostic imaging |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aBowman, L C | |
| 700 | 1 | _aFurman, W L | |
| 700 | 1 | _aRao, B N | |
| 700 | 1 | _aKun, L E | |
| 700 | 1 | _aJenkins, J J | |
| 700 | 1 | _aCrom, W R | |
| 700 | 1 | _aLuo, X | |
| 700 | 1 | _aKaste, S C | |
| 700 | 1 | _aAvery, L | |
| 700 | 1 | _aMeyer, W H | |
| 700 | 1 | _aShapiro, D N | |
| 700 | 1 | _aCrist, W M | |
| 773 | 0 |
_tJournal of pediatric hematology/oncology _gvol. 19 _gno. 5 _gp. 438-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00043426-199709000-00006 _zAvailable from publisher's website |
| 999 |
_c9302394 _d9302394 |
||